Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 151

1.

Computed Tomography Total Airway Count is Associated with Number of Micro-CT Terminal Bronchioles.

Kirby M, Tanabe N, Vasilescu DM, Cooper JD, McDonough JE, Verleden SE, Vanaudenaerde BM, Sin DD, Tan WC, Coxson HO, Hogg JC.

Am J Respir Crit Care Med. 2019 Nov 7. doi: 10.1164/rccm.201910-1948LE. [Epub ahead of print] No abstract available.

PMID:
31697561
2.

Total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation: a single-center experience and review of literature.

Lebeer M, Kaes J, Lambrech M, Vanstapel A, Beeckmans H, Ambrocio GPL, Vanaudenaerde BM, Verleden SE, Verbeken EK, Neyrinck AP, Ceulemans LJ, Van Raemdonck DE, Verleden GM, Vos R; Leuven Lung Transplant Group.

Transpl Int. 2019 Oct 23. doi: 10.1111/tri.13544. [Epub ahead of print]

PMID:
31643104
3.

Mortality after lung transplantation: a single-centre cohort analysis.

Raskin J, Vanstapel A, Verbeken EK, Beeckmans H, Vanaudenaerde BM, Verleden SE, Neyrinck AP, Ceulemans LJ, Van Raemdonck DE, Verleden GM, Vos R; Leuven Lung Transplant Group.

Transpl Int. 2019 Oct 15. doi: 10.1111/tri.13540. [Epub ahead of print]

PMID:
31612514
4.

Transcriptional regulatory model of fibrosis progression in the human lung.

McDonough JE, Ahangari F, Li Q, Jain S, Verleden SE, Herazo-Maya J, Vukmirovic M, DeIuliis G, Tzouvelekis A, Tanabe N, Chu F, Yan X, Verschakelen J, Homer RJ, Manatakis DV, Zhang J, Ding J, Maes K, De Sadeleer L, Vos R, Neyrinck A, Benos PV, Bar-Joseph Z, Tantin D, Hogg JC, Vanaudenaerde BM, Wuyts WA, Kaminski N.

JCI Insight. 2019 Nov 14;4(22). pii: 131597. doi: 10.1172/jci.insight.131597.

5.

Airway morphometry in COPD with bronchiectasis: a view on all airway generations.

Everaerts S, McDonough JE, Verleden SE, Josipovic I, Boone M, Dubbeldam A, Mathyssen C, Serré J, Dupont LJ, Gayan-Ramirez G, Verschakelen J, Hogg JC, Verleden GM, Vanaudenaerde BM, Janssens W.

Eur Respir J. 2019 Nov 7;54(5). pii: 1802166. doi: 10.1183/13993003.02166-2018. Print 2019 Nov.

PMID:
31467117
6.

Intragraft donor-specific anti-HLA antibodies in phenotypes of chronic lung allograft dysfunction.

Sacreas A, Taupin JL, Emonds MP, Daniëls L, Van Raemdonck DE, Vos R, Verleden GM, Vanaudenaerde BM, Roux A, Verleden SE; and the Leuven Lung Transplant Group.

Eur Respir J. 2019 Nov 7;54(5). pii: 1900847. doi: 10.1183/13993003.00847-2019. Print 2019 Nov.

PMID:
31439680
7.

Myeloid-Derived Suppressor Cells in Lung Transplantation.

Heigl T, Singh A, Saez-Gimenez B, Kaes J, Van Herck A, Sacreas A, Beeckmans H, Vanstapel A, Verleden SE, Van Raemdonck DE, Verleden G, Vanaudenaerde BM, Hartl D, Vos R.

Front Immunol. 2019 Apr 26;10:900. doi: 10.3389/fimmu.2019.00900. eCollection 2019.

8.

Cell-Free DNA and CXCL10 Derived from Bronchoalveolar Lavage Predict Lung Transplant Survival.

Yang JYC, Verleden SE, Zarinsefat A, Vanaudenaerde BM, Vos R, Verleden GM, Sarwal RD, Sigdel TK, Liberto JM, Damm I, Watson D, Sarwal MM.

J Clin Med. 2019 Feb 13;8(2). pii: E241. doi: 10.3390/jcm8020241.

9.

Phenotypical diversity of airway morphology in chronic lung graft vs. host disease after stem cell transplantation.

Verleden SE, McDonough JE, Schoemans H, Knoop C, Verschakelen J, Dubbeldam A, Boone MN, Van Hoorebeke L, Verbeken E, Weynand B, Van Raemdonck D, Verleden GM, Vos R, Vanaudenaerde BM.

Mod Pathol. 2019 Jun;32(6):817-829. doi: 10.1038/s41379-019-0203-2. Epub 2019 Feb 5.

PMID:
30723292
10.

Azithromycin and early allograft function after lung transplantation: A randomized, controlled trial.

Van Herck A, Frick AE, Schaevers V, Vranckx A, Verbeken EK, Vanaudenaerde BM, Sacreas A, Heigl T, Neyrinck AP, Van Raemdonck D, Dupont LJ, Yserbyt J, Verleden SE, Verleden GM, Vos R.

J Heart Lung Transplant. 2019 Mar;38(3):252-259. doi: 10.1016/j.healun.2018.12.006. Epub 2018 Dec 14.

PMID:
30686699
11.

Montelukast in chronic lung allograft dysfunction after lung transplantation.

Vos R, Eynde RV, Ruttens D, Verleden SE, Vanaudenaerde BM, Dupont LJ, Yserbyt J, Verbeken EK, Neyrinck AP, Van Raemdonck DE, Verleden GM; Leuven Lung Transplant Group.

J Heart Lung Transplant. 2019 May;38(5):516-527. doi: 10.1016/j.healun.2018.11.014. Epub 2018 Dec 6.

PMID:
30638839
12.

Validation of a post-transplant chronic lung allograft dysfunction classification system.

Van Herck A, Verleden SE, Sacreas A, Heigl T, Vanaudenaerde BM, Dupont LJ, Yserbyt J, Verbeken EK, Neyrinck AP, Van Raemdonck D, Verleden GM, Vos R.

J Heart Lung Transplant. 2019 Feb;38(2):166-173. doi: 10.1016/j.healun.2018.09.020. Epub 2018 Oct 4.

PMID:
30391199
13.

Gene correlation network analysis to identify regulatory factors in idiopathic pulmonary fibrosis.

McDonough JE, Kaminski N, Thienpont B, Hogg JC, Vanaudenaerde BM, Wuyts WA.

Thorax. 2019 Feb;74(2):132-140. doi: 10.1136/thoraxjnl-2018-211929. Epub 2018 Oct 26.

14.

The common rejection module in chronic rejection post lung transplantation.

Sacreas A, Yang JYC, Vanaudenaerde BM, Sigdel TK, Liberto JM, Damm I, Verleden GM, Vos R, Verleden SE, Sarwal MM.

PLoS One. 2018 Oct 5;13(10):e0205107. doi: 10.1371/journal.pone.0205107. eCollection 2018.

15.

Role of 18F-FDG PET/CT in Restrictive Allograft Syndrome After Lung Transplantation.

Verleden SE, Gheysens O, Goffin KE, Vanaudenaerde BM, Verbeken EK, Weynand B, Van Raemdonck DE, Verleden GM, Vos R.

Transplantation. 2019 Apr;103(4):823-831. doi: 10.1097/TP.0000000000002393.

PMID:
30086092
16.

Pirfenidone in restrictive allograft syndrome after lung transplantation: A case series.

Vos R, Wuyts WA, Gheysens O, Goffin KE, Schaevers V, Verleden SE, Van Herck A, Sacreas A, Heigl T, McDonough JE, Yserbyt J, Godinas L, Dupont LJ, Neyrinck AP, Van Raemdonck DE, Verbeken EK, Vanaudenaerde BM, Verleden GM.

Am J Transplant. 2018 Dec;18(12):3045-3059. doi: 10.1111/ajt.15019. Epub 2018 Aug 17.

17.

A role for telomere length and chromosomal damage in idiopathic pulmonary fibrosis.

McDonough JE, Martens DS, Tanabe N, Ahangari F, Verleden SE, Maes K, Verleden GM, Kaminski N, Hogg JC, Nawrot TS, Wuyts WA, Vanaudenaerde BM.

Respir Res. 2018 Jul 9;19(1):132. doi: 10.1186/s12931-018-0838-4.

18.

Clinical behaviour of patients exposed to organic dust and diagnosed with idiopathic pulmonary fibrosis.

De Sadeleer LJ, Verleden SE, De Dycker E, Yserbyt J, Verschakelen JA, Verbeken EK, Nemery B, Verleden GM, Hermans F, Vanaudenaerde BM, Wuyts WA.

Respirology. 2018 Dec;23(12):1160-1165. doi: 10.1111/resp.13342. Epub 2018 Jun 13.

PMID:
29897160
19.

The aging lung: tissue telomere shortening in health and disease.

Everaerts S, Lammertyn EJ, Martens DS, De Sadeleer LJ, Maes K, van Batenburg AA, Goldschmeding R, van Moorsel CHM, Dupont LJ, Wuyts WA, Vos R, Gayan-Ramirez G, Kaminski N, Hogg JC, Janssens W, Verleden GM, Nawrot TS, Verleden SE, McDonough JE, Vanaudenaerde BM.

Respir Res. 2018 May 11;19(1):95. doi: 10.1186/s12931-018-0794-z.

20.

Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A randomized controlled trial.

Ruttens D, Verleden SE, Demeyer H, Van Raemdonck DE, Yserbyt J, Dupont LJ, Vanaudenaerde BM, Vos R, Verleden GM.

PLoS One. 2018 Apr 6;13(4):e0193564. doi: 10.1371/journal.pone.0193564. eCollection 2018.

21.

Analysis of airway pathology in COPD using a combination of computed tomography, micro-computed tomography and histology.

Tanabe N, Vasilescu DM, Kirby M, Coxson HO, Verleden SE, Vanaudenaerde BM, Kinose D, Nakano Y, Paré PD, Hogg JC.

Eur Respir J. 2018 Feb 14;51(2). pii: 1701245. doi: 10.1183/13993003.01245-2017. Print 2018 Feb.

22.

Aspergillus fumigatus Detection and Risk Factors in Patients with COPD-Bronchiectasis Overlap.

Everaerts S, Lagrou K, Vermeersch K, Dupont LJ, Vanaudenaerde BM, Janssens W.

Int J Mol Sci. 2018 Feb 9;19(2). pii: E523. doi: 10.3390/ijms19020523.

23.

Immediate post-operative broncho-alveolar lavage IL-6 and IL-8 are associated with early outcomes after lung transplantation.

Verleden SE, Martens A, Ordies S, Neyrinck AP, Van Raemdonck DE, Verleden GM, Vanaudenaerde BM, Vos R.

Clin Transplant. 2018 Apr;32(4):e13219. doi: 10.1111/ctr.13219. Epub 2018 Feb 23.

PMID:
29405435
24.

Epithelial grafting of a decellularized whole-tracheal segment: an in vivo experimental model.

Den Hondt M, Vanaudenaerde BM, Verbeken EK, Vranckx JJ.

Interact Cardiovasc Thorac Surg. 2018 May 1;26(5):753-760. doi: 10.1093/icvts/ivx442.

PMID:
29346567
25.

Prevention of chronic rejection after lung transplantation.

Van Herck A, Verleden SE, Vanaudenaerde BM, Verleden GM, Vos R.

J Thorac Dis. 2017 Dec;9(12):5472-5488. doi: 10.21037/jtd.2017.11.85. Review.

26.

Association of innate defense proteins BPIFA1 and BPIFB1 with disease severity in COPD.

De Smet EG, Seys LJ, Verhamme FM, Vanaudenaerde BM, Brusselle GG, Bingle CD, Bracke KR.

Int J Chron Obstruct Pulmon Dis. 2017 Dec 19;13:11-27. doi: 10.2147/COPD.S144136. eCollection 2018.

27.

Donor-specific and -nonspecific HLA antibodies and outcome post lung transplantation.

Verleden SE, Vanaudenaerde BM, Emonds MP, Van Raemdonck DE, Neyrinck AP, Verleden GM, Vos R.

Eur Respir J. 2017 Nov 16;50(5). pii: 1701248. doi: 10.1183/13993003.01248-2017. Print 2017 Nov.

28.

Chronic lung allograft dysfunction phenotypes and treatment.

Verleden SE, Vos R, Vanaudenaerde BM, Verleden GM.

J Thorac Dis. 2017 Aug;9(8):2650-2659. doi: 10.21037/jtd.2017.07.81. Review.

29.

Sensitization to Aspergillus fumigatus as a risk factor for bronchiectasis in COPD.

Everaerts S, Lagrou K, Dubbeldam A, Lorent N, Vermeersch K, Van Hoeyveld E, Bossuyt X, Dupont LJ, Vanaudenaerde BM, Janssens W.

Int J Chron Obstruct Pulmon Dis. 2017 Aug 31;12:2629-2638. doi: 10.2147/COPD.S141695. eCollection 2017.

30.

Solid Organ Transplantation in Sarcoidosis.

Yserbyt J, Wuyts WA, Verleden SE, Verleden GM, Van Raemdonck DE, Verbeken EK, Vanaudenaerde BM, Vos R.

Semin Respir Crit Care Med. 2017 Aug;38(4):538-545. doi: 10.1055/s-0037-1602383. Epub 2017 Jul 27. Review. No abstract available.

PMID:
28750467
31.

An optimized non-destructive protocol for testing mechanical properties in decellularized rabbit trachea.

Den Hondt M, Vanaudenaerde BM, Maughan EF, Butler CR, Crowley C, Verbeken EK, Verleden SE, Vranckx JJ.

Acta Biomater. 2017 Sep 15;60:291-301. doi: 10.1016/j.actbio.2017.07.035. Epub 2017 Jul 21.

PMID:
28739545
32.

Immunoregulatory effects of multipotent adult progenitor cells in a porcine ex vivo lung perfusion model.

Martens A, Ordies S, Vanaudenaerde BM, Verleden SE, Vos R, Van Raemdonck DE, Verleden GM, Roobrouck VD, Claes S, Schols D, Verbeken E, Verfaillie CM, Neyrinck AP.

Stem Cell Res Ther. 2017 Jul 5;8(1):159. doi: 10.1186/s13287-017-0603-5.

33.

A retrospective database analysis to evaluate the potential of ex vivo lung perfusion to recruit declined lung donors.

Martens A, Van Raemdonck DE, Smits J, Verleden SE, Vos R, Vanaudenaerde BM, Verleden GM, Degezelle K, Desschans B, Neyrinck AP.

Transpl Int. 2017 Oct;30(10):1002-1010. doi: 10.1111/tri.12990. Epub 2017 Jul 13.

34.

A porcine ex vivo lung perfusion model with maximal argon exposure to attenuate ischemia-reperfusion injury.

Martens A, Ordies S, Vanaudenaerde BM, Verleden SE, Vos R, Verleden GM, Verbeken EK, Van Raemdonck DE, Claes S, Schols D, Chalopin M, Katz I, Farjot G, Neyrinck AP.

Med Gas Res. 2017 Mar 30;7(1):28-36. doi: 10.4103/2045-9912.202907. eCollection 2017 Jan-Mar.

35.

The Effect of Immunosuppression on Airway Integrity.

Bellon H, Vandermeulen E, Verleden SE, Heigl T, Vriens H, Lammertyn E, Verlinden L, Vanhove T, Verstuyf M, Hoet P, Vos R, Verleden GM, Vanaudenaerde BM.

Transplantation. 2017 Dec;101(12):2855-2861. doi: 10.1097/TP.0000000000001809.

PMID:
28471870
36.

Post-transplant lymphoproliferative disease in lung transplantation: A nested case-control study.

Leyssens A, Dierickx D, Verbeken EK, Tousseyn T, Verleden SE, Vanaudenaerde BM, Dupont LJ, Yserbyt J, Verleden GM, Van Raemdonck DE, Vos R.

Clin Transplant. 2017 Jul;31(7). doi: 10.1111/ctr.12983. Epub 2017 May 8.

PMID:
28383790
37.

High-dose vitamin D after lung transplantation: A randomized trial.

Vos R, Ruttens D, Verleden SE, Vandermeulen E, Bellon H, Van Herck A, Sacreas A, Heigl T, Schaevers V, Van Raemdonck DE, Verbeken EK, Neyrinck AP, Dupont LJ, Yserbyt J, Vanaudenaerde BM, Verleden GM.

J Heart Lung Transplant. 2017 Aug;36(8):897-905. doi: 10.1016/j.healun.2017.03.008. Epub 2017 Mar 8.

PMID:
28365177
38.

Short- and Long-term Outcomes After Lung Transplantation From Circulatory-Dead Donors: A Single-Center Experience.

Ruttens D, Martens A, Ordies S, Verleden SE, Neyrinck AP, Vos R, Boada MC, Vanaudenaerde BM, Verleden GM, Van Raemdonck D.

Transplantation. 2017 Nov;101(11):2691-2694. doi: 10.1097/TP.0000000000001678.

PMID:
28207629
39.

Interleukin-1α induced release of interleukin-8 by human bronchial epithelial cells in vitro: assessing mechanisms and possible treatment options.

Bellon H, Vandermeulen E, Mathyssen C, Sacreas A, Verleden SE, Heigl T, Vriens H, Lammertyn E, Pilette C, Hoet P, Vos R, Vanaudenaerde BM, Verleden GM.

Transpl Int. 2017 Apr;30(4):388-397. doi: 10.1111/tri.12915. Epub 2017 Mar 2.

40.

End-stage cystic fibrosis lung disease is characterised by a diverse inflammatory pattern: an immunohistochemical analysis.

Lammertyn EJ, Vandermeulen E, Bellon H, Everaerts S, Verleden SE, Van Den Eynde K, Bracke KR, Brusselle GG, Goeminne PC, Verbeken EK, Vanaudenaerde BM, Dupont LJ.

Respir Res. 2017 Jan 10;18(1):10. doi: 10.1186/s12931-016-0489-2.

41.

Immunological diversity in phenotypes of chronic lung allograft dysfunction: a comprehensive immunohistochemical analysis.

Vandermeulen E, Lammertyn E, Verleden SE, Ruttens D, Bellon H, Ricciardi M, Somers J, Bracke KR, Van Den Eynde K, Tousseyn T, Brusselle GG, Verbeken EK, Verschakelen J, Emonds MP, Van Raemdonck DE, Verleden GM, Vos R, Vanaudenaerde BM.

Transpl Int. 2017 Feb;30(2):134-143. doi: 10.1111/tri.12882. Epub 2016 Dec 8.

42.

Nondestructive cryomicro-CT imaging enables structural and molecular analysis of human lung tissue.

Vasilescu DM, Phillion AB, Tanabe N, Kinose D, Paige DF, Kantrowitz JJ, Liu G, Liu H, Fishbane N, Verleden SE, Vanaudenaerde BM, Lenburg M, Stevenson CS, Spira A, Cooper JD, Hackett TL, Hogg JC.

J Appl Physiol (1985). 2017 Jan 1;122(1):161-169. doi: 10.1152/japplphysiol.00838.2016. Epub 2016 Nov 17.

43.

An association of particulate air pollution and traffic exposure with mortality after lung transplantation in Europe.

Ruttens D, Verleden SE, Bijnens EM, Winckelmans E, Gottlieb J, Warnecke G, Meloni F, Morosini M, Van Der Bij W, Verschuuren EA, Sommerwerck U, Weinreich G, Kamler M, Roman A, Gomez-Olles S, Berastegui C, Benden C, Holm AM, Iversen M, Schultz HH, Luijk B, Oudijk EJ, Kwakkel-van Erp JM, Jaksch P, Klepetko W, Kneidinger N, Neurohr C, Corris P, Fisher AJ, Lordan J, Meachery G, Piloni D, Vandermeulen E, Bellon H, Hoffmann B, Vienneau D, Hoek G, de Hoogh K, Nemery B, Verleden GM, Vos R, Nawrot TS, Vanaudenaerde BM.

Eur Respir J. 2017 Jan 18;49(1). pii: 1600484. doi: 10.1183/13993003.00484-2016. Print 2017 Jan.

44.

Steroids can reduce warm ischemic reperfusion injury in a porcine donation after circulatory death model with ex vivo lung perfusion evaluation.

Martens A, Boada M, Vanaudenaerde BM, Verleden SE, Vos R, Verleden GM, Verbeken EK, Van Raemdonck D, Schols D, Claes S, Neyrinck AP.

Transpl Int. 2016 Nov;29(11):1237-1246. doi: 10.1111/tri.12823.

45.

Parametric Response Mapping of Bronchiolitis Obliterans Syndrome Progression After Lung Transplantation.

Verleden SE, Vos R, Vandermeulen E, Ruttens D, Bellon H, Heigl T, Van Raemdonck DE, Verleden GM, Lama V, Ross BD, Galbán CJ, Vanaudenaerde BM.

Am J Transplant. 2016 Nov;16(11):3262-3269. doi: 10.1111/ajt.13945. Epub 2016 Jul 29.

46.

Phenotypes of Chronic Lung Allograft Dysfunction: Getting Closer Step by Step?

Verleden SE, Vanaudenaerde BM, Vos R, Verleden GM.

Am J Transplant. 2016 Nov;16(11):3071-3072. doi: 10.1111/ajt.13921. Epub 2016 Jul 13. No abstract available.

47.

The role of recipient derived interleukin-17A in a murine orthotopic lung transplant model of restrictive chronic lung allograft dysfunction.

Yamada Y, Vandermeulen E, Heigl T, Somers J, Vaneylen A, Verleden SE, Bellon H, De Vleeschauwer S, Verbeken EK, Van Raemdonck DE, Vos R, Verleden GM, Jungraithmayr W, Vanaudenaerde BM.

Transpl Immunol. 2016 Nov;39:10-17. doi: 10.1016/j.trim.2016.10.001. Epub 2016 Oct 11.

PMID:
27737799
48.

Thin-Section CT Features of Idiopathic Pulmonary Fibrosis Correlated with Micro-CT and Histologic Analysis.

Mai C, Verleden SE, McDonough JE, Willems S, De Wever W, Coolen J, Dubbeldam A, Van Raemdonck DE, Verbeken EK, Verleden GM, Hogg JC, Vanaudenaerde BM, Wuyts WA, Verschakelen JA.

Radiology. 2017 Apr;283(1):252-263. doi: 10.1148/radiol.2016152362. Epub 2016 Oct 6.

49.

Tracheal tissue-engineering: in-vivo biocompatibility of mechanically-stripped allogenic rabbit trachea with autologous epithelial covering.

Den Hondt M, Vanaudenaerde BM, Verbeken EK, Vranckx JJ.

Acta Chir Belg. 2016 Jun;116(3):164-174. doi: 10.1080/00015458.2016.1210844. Epub 2016 Oct 4.

PMID:
27696973
50.

Humoral immunity in phenotypes of chronic lung allograft dysfunction: A broncho-alveolar lavage fluid analysis.

Vandermeulen E, Verleden SE, Bellon H, Ruttens D, Lammertyn E, Claes S, Vandooren J, Ugarte-Berzal E, Schols D, Emonds MP, Van Raemdonck DE, Opdenakker G, Verleden GM, Vos R, Vanaudenaerde BM.

Transpl Immunol. 2016 Sep;38:27-32. doi: 10.1016/j.trim.2016.08.004. Epub 2016 Aug 22.

PMID:
27561239

Supplemental Content

Loading ...
Support Center